A drug sustained-release preparation containing dezocine and its preparation method

A sustained-release preparation, the technology of dezocine, applied in the field of medicine, achieves the effect of relieving pain and stabilizing drug release speed
CN110101865BActive Publication Date: 2020-04-10TIANJIN CITY THIRD CENT HOSPITAL

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
TIANJIN CITY THIRD CENT HOSPITAL
Publication Date
2020-04-10

Smart Images

  • Figure 1
    Figure 1
Patent Text Reader

Abstract

The invention provides a dizocine-containing medicine sustained-release preparation and a preparation method thereof. The dizocine-containing medicine sustained-release preparation is prepared from, by weight, 1-10 parts of dezocine, 1-10 parts of a polylactic acid-hydroxyacetic acid block copolymer, 1-10 parts of a dissolution aiding additive, 1-10 parts of an osmotic pressure regulator, 0.1-0.5part of a pH value stabilizer, 1-5 parts of a wetting agent, 1-10 parts of a freeze-dried powder protectant, 10-50 parts of an organic solvent and 100-1000 parts of water for injection. Compared withan existing dezocine injection reagent, the dezocine is encapsulated in a biocompatible high-molecular polymer, the medicine can be released slowly, the release speed of the medicine is stable, the stable blood concentration can be maintained for 8h or more after single-time administration, the pain of a patient can be effectively relieved, and the dezocine injection reagent can be used for relieving the pain of the patient after the operation.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention belongs to the technical field of medicine, and relates to a pharmaceutical composition for anesthesia and analgesic injection and a preparation method thereof, in particular to a drug sustained-release preparation containing dezocine and a preparation method thereof. Background technique

[0002] Dezocine is a mixed agonist-antagonist of opioid receptors, which is a small-molecule highly fat-soluble drug that fully agonizes κ receptors and partially agonizes and partially antagonizes μ receptors. When the blood concentration of dazocine reaches 5-9 μg / L, it will produce analgesic effect, and the analgesic effect is strong, and its analgesic effect is 5-9 times that of pethidine, which is equivalent to morphine. Studies have shown that the spinal cord κ receptor is an important target for dezocine to produce analgesic effect. Dezocine absorbs quickly in the body, distributes rapidly, and has a long half-life, so its analgesic effect has ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More